A 2015 Cochrane database critique observed insufficient evidence to justify the use of G. lucidum as a first-line cancer treatment.[5][6] It said that G. lucidum may have "benefit in its place adjunct to conventional procedure in thing to consider of its likely of improving tumour reaction and stimulating host immunity. https://gold-ira-reviews65420.jiliblog.com/89432557/considerations-to-know-about-reishi-mushroom